MOST RECENT

COVID-19 Resources

Colorado COVID-19 Tracker

Discussion forum

Town Hall Webinars

Virtual Grand Rounds

CDPHE Contact Information

For local public health agencies and healthcare providers only:

  • From Monday thru Friday, 8:30 a.m.- 5:00 p.m., please call 303-692-2700.
  • For after-hours, holidays, and weekends, please call 303-370-9395.

For general questions about COVID-19:

  • Call CO-HELP at 303-389-1687 or 1-877-462-2911.
  • You can also email COHELP@RMPDC.org for answers in English.

COVID-19 vaccine news roundup: Aug. 26, 2021


FDA grants full approval to Pfizer COVID-19 vaccine
On Aug. 23, 2021, the Food and Drug Administration (FDA) granted full approval to the Pfizer-BioNTech vaccine, marketed as Comirnaty, for individuals age 16 and older. The vaccine is available under emergency use authorization for individuals ages 12-15.

FDA authorized third dose of COVID-19 vaccine for certain individuals
On Aug. 12, the FDA authorized an additional dose of mRNA vaccine (Pfizer or Moderna) for moderately to severely immunocompromised people due to a medical condition or receipt of immunosuppressive medications or treatments.

Direction for physicians and their patients

  • Physicians should continue to recommend COVID-19 vaccination for all eligible individuals, including women who are pregnant, lactating, trying to conceive or might conceive in the future.
  • Fully vaccinated people who come into close contact with someone with COVID-19 should get tested 3-5 days after the date of the exposure and wear a mask in public indoor settings for 14 days after exposure or until a negative test result.
More information is available in the CDPHE Health Alert Network Broadcast sent on Aug. 26, 2021.